Back to Search
Start Over
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial.
- Source :
- Neurology; 4/3/2012, Vol. 78 Issue 14, p1069-1078, 10p
- Publication Year :
- 2012
Details
- Language :
- English
- ISSN :
- 00283878
- Volume :
- 78
- Issue :
- 14
- Database :
- Supplemental Index
- Journal :
- Neurology
- Publication Type :
- Academic Journal
- Accession number :
- 95340331
- Full Text :
- https://doi.org/10.1212/wnl.0b013e31824e8ee7